Kajal Chakraborty Selected Research

Kajal Chakraborty Research Topics

Disease

9	Inflammation (Inflammations) 03/2023 - 01/2018
7	Hypertension (High Blood Pressure) 11/2022 - 05/2019
4	Pneumonia (Pneumonitis) 02/2022 - 08/2020
3	Neoplasms (Cancer) 11/2022 - 11/2020
3	Cross Infection (Nosocomial Infection) 01/2022 - 08/2020
3	Male Infertility (Male Sterility) 09/2006 - 07/2005
3	Infertility (Sterility) 03/2006 - 02/2003
2	Chronic Disease (Chronic Diseases) 03/2023 - 07/2021
2	Hepatocellular Carcinoma (Hepatoma) 11/2022 - 01/2021
2	Cardiomegaly (Heart Hypertrophy) 11/2020 - 02/2019
1	Ductal Carcinoma 11/2022
1	Infections 09/2022
1	Wounds and Injuries (Trauma) 09/2022
1	Osteoporosis 11/2021
1	Liver Neoplasms (Liver Cancer) 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Diabetes Mellitus 01/2021
1	Bacterial Infections (Bacterial Infection) 05/2020
1	Hypercholesterolemia 05/2019
1	Hyperglycemia 01/2019
1	Edema (Dropsy) 05/2018
1	Intellectual Disability (Idiocy) 12/2016
1	Blindness (Hysterical Blindness) 12/2016
1	Alzheimer Disease (Alzheimer's Disease) 01/2016
1	Rheumatoid Arthritis 01/2016
1	Atherosclerosis 01/2016
1	Dementia (Dementias) 01/2016

Drug/Important Bio-Agent (IBA)

7	Angiotensin IIIBA 11/2022 - 02/2019
6	Anti-Bacterial Agents (Antibiotics)IBA 02/2022 - 05/2020
5	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 11/2022 - 05/2019
5	EnzymesIBA 11/2021 - 01/2019
4	Angiotensin IIBA 11/2022 - 12/2021
4	Vancomycin FDA LinkGeneric 02/2022 - 08/2020
3	Proteins (Proteins, Gene)FDA Link 11/2022 - 12/2020
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2022 - 12/2021
3	Ampicillin (Omnipen)FDA LinkGeneric 02/2022 - 08/2020
3	Chloramphenicol (Chloromycetin)FDA Link 02/2022 - 08/2020
3	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 03/2021 - 05/2019
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 03/2021 - 10/2020
2	CytokinesIBA 03/2023 - 12/2020
2	Vasoconstrictor AgentsIBA 11/2022 - 03/2022
2	galactofucanIBA 11/2022 - 07/2021
2	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 01/2019
2	Polysaccharides (Glycans)IBA 07/2021 - 11/2020
2	Biomarkers (Surrogate Marker)IBA 07/2021 - 01/2021
2	Polyketide SynthasesIBA 08/2020 - 05/2020
2	LactonesIBA 08/2020 - 02/2019
2	OxalatesIBA 10/2005 - 02/2003
1	Messenger RNA (mRNA)IBA 03/2023
1	Interleukin-2 (IL2)IBA 03/2023
1	InterferonsIBA 03/2023
1	Tumor Suppressor Protein p53IBA 11/2022
1	Galactose (Galactopyranose)FDA LinkGeneric 11/2022
1	Clindamycin (Cleocin)FDA LinkGeneric 09/2022
1	PolyketidesIBA 01/2022
1	Biopolymers (Biopolymer)IBA 11/2021
1	GlucocorticoidsIBA 11/2021
1	difficidinIBA 08/2021
1	Troponin IIBA 07/2021
1	Antihypertensive Agents (Antihypertensives)IBA 07/2021
1	Troponin T (Troponin T1)IBA 07/2021
1	Telmisartan (Micardis)FDA Link 07/2021
1	SaltsIBA 01/2021
1	4-chromanoneIBA 01/2021
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 12/2020
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 12/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2020
1	Ibuprofen (Motrin)FDA LinkGeneric 12/2020
1	ChemokinesIBA 12/2020
1	LipopolysaccharidesIBA 12/2020
1	InterleukinsIBA 12/2020
1	ziconotide (Prialt)FDA Link 11/2020
1	elisidepsinIBA 11/2020
1	Analgesics (Analgesic Drugs)IBA 11/2020
1	ProstaglandinsIBA 10/2020
1	Malonyl Coenzyme A (Malonyl CoA)IBA 08/2020
1	non-ribosomal peptide synthaseIBA 05/2020
1	Oxidoreductases (Dehydrogenase)IBA 05/2019
1	Coenzyme A (CoA)IBA 05/2019
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 05/2019
1	Hormones (Hormone)IBA 01/2019
1	CarbohydratesIBA 01/2019
1	IncretinsIBA 01/2019
1	CarrageenanIBA 05/2018
1	LigandsIBA 01/2018
1	MicronutrientsIBA 12/2016
1	Retinaldehyde (Retinal)IBA 01/2016
1	Eicosapentaenoic AcidIBA 01/2016
1	Docosahexaenoic AcidsIBA 01/2016
1	ChlorineIBA 09/2006
1	AcetanilidesIBA 09/2006
1	F 4 (F-4)IBA 03/2006
1	PyridonesIBA 03/2006
1	HalogensIBA 10/2005
1	Alanine (L-Alanine)FDA Link 10/2005
1	Amino Acids FDA Link 10/2005
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 10/2005
1	AmidesIBA 10/2005

Therapy/Procedure

1	Therapeutics 11/2020